Resources

Resources & Insights

Stay informed with the latest rebate insights, compliance updates, and industry shifts through our articles, event coverage, and pharmacy bulletins.

All Resources

VativoRx News

VativoRx Joins MHA: A New Chapter Begins

Learn more →
October 13, 2023
VativoRx News

Unveiling the Future: Navigating the Evolving Landscape of 340B Rebates.

Learn more →
May 25, 2023
VativoRx News

Humira – The End of an Era

Learn more →
April 11, 2023
Case Study & Webinars

Innovative Revenue Solutions in Healthcare: VativoRx CEO Lisa Quarterman’s Insights in the Solutions Spotlight Series

Read Case Study →
March 6, 2023
VativoRx News

Drug Shortages and Stockpiling: What You Need to Know

Learn more →
February 20, 2023
VativoRx News

Biosimilars — Similar But Not Identical

Learn more →
October 31, 2022
VativoRx News

Lower Cost Prescription Drugs from Canada, Is It Legal?

Learn more →
September 8, 2022
VativoRx News

PBMs to FTC: We are the best hope for lowering prescription drug cost

Learn more →
April 28, 2022
VativoRx News

Seeing the future of self-insurance

Learn more →
April 26, 2022
VativoRx News

Independent pharmacies are not disappearing any time soon

Learn more →
April 12, 2022
VativoRx News

Why have people loved their “Mom & Pop” pharmacies for generations?

Learn more →
April 11, 2022
VativoRx News

Generic drug growth may slow with approval of more complex medicines

Learn more →
April 9, 2022

Pharmacy Bulletin

Periodic updates on pharmacy benefit programs, rebate activity, and regulatory changes.